Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$VRTX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $4.34 up 7.96% YoY • Reported revenue of $3.33B up 12.45% YoY • Vertex Pharmaceuticals raised its full year 2026 total revenue guidance to $13.1 billion to $13.2 billion, while reiterating guidance for combined GAAP and non-GAAP R&D, AIPR&D, and SG&A expenses.

Price since post

Full Details

Advertisement|Remove ads.